Accessibility Menu
Owens & Minor Stock Quote

Owens & Minor (NYSE: OMI)

$5.21
(3.0%)
+0.15
Price as of October 22, 2025, 1:04 p.m. ET

KEY DATA POINTS

Current Price
$5.21
Daily Change
(3.0%) +$0.15
Day's Range
$5.01 - $5.28
Previous Close
$5.06
Open
$5.09
Beta
1.17
Volume
766,342
Average Volume
2,112,812
Market Cap
390.9M
Market Cap / Employee
$5.06M
52wk Range
$4.34 - $15.54
Revenue
-
Gross Margin
0.20%
Dividend Yield
N/A
EPS
-$15.62
CAPs Rating
-
Industry
Healthcare Providers and Services

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Owens & Minor Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
OMI-63.17%-79.14%-26.91%+103%
S&P+15.06%+95.03%+14.29%+3,880%

Owens & Minor Company Info

Owens & Minor, Inc. is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments. The Products and Healthcare Services segment includes medical distribution, the outsourced logistics and value-added services business, and global products, which manufacture and source medical surgical products through the production and kitting operations. The Patient Direct segments includes the home healthcare business, Byram and Apria. The company was founded by Otho O. Owens and G. Gilmer Minor in 1882 and is headquartered in Mechanicsville, VA.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$681.92M-74.5%
Gross Profit$297.09M-38.1%
Gross Margin43.57%25.6%
Market Cap$697.19M-32.5%
Market Cap / Employee$0.03M0.0%
Employees23.2K4.5%
Net Income-$83.82M-162.7%
EBITDA$108.67M-15.8%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$38.26M-85.1%
Accounts Receivable$196.38M-70.4%
Inventory69.2-94.4%

Liabilities

Q2 2025YOY Change
Long Term Debt$1.68B-22.8%
Short Term Debt$426.70M97.2%

Ratios

Q2 2025YOY Change
Return On Assets-8.83%-8.0%
Return On Invested Capital0.26%-2.5%

Cash Flow

Q2 2025YOY Change
Free Cash Flow-$30.27M-142.2%
Operating Free Cash Flow$37.61M-67.6%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Book1.401.151.231.236.71%
Price to Sales0.110.090.070.08-18.47%
Price to Tangible Book Value-1.10-0.93-0.63-0.67-29.50%
Price to Free Cash Flow TTM2.736.257.20315.31-
Enterprise Value to EBITDA22.6323.0326.1425.443.77%
Free Cash Flow Yield36.7%16.0%13.9%0.3%-
Return on Equity-5.5%-48.7%-49.9%-144.1%2882.82%
Total Debt$2.17B$2.23B$2.27B$2.10B-11.88%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.